Related references
Note: Only part of the references are listed.Impact of delayed treatment in women diagnosed with breast cancer: A population-based study
Peh Joo Ho et al.
CANCER MEDICINE (2020)
Adherence to oral chemotherapy: Challenges and opportunities
Susan Krikorian et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Patient perspectives on the barriers associated with medication adherence to oral chemotherapy
Benyam Muluneh et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli et al.
LANCET ONCOLOGY (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Health Literacy and Access to Care
Helen Levy et al.
JOURNAL OF HEALTH COMMUNICATION (2016)
Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib
David Marin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Recognizing and overcoming inadequate health literacy, a barrier to care
MV Williams
CLEVELAND CLINIC JOURNAL OF MEDICINE (2002)
Share Paper
